Your browser doesn't support javascript.
loading
Incidence of cytomegalovirus infection in seropositive kidney transplant recipients treated with everolimus: A randomized, open-label, multicenter phase 4 trial.
Kaminski, Hannah; Kamar, Nassim; Thaunat, Olivier; Bouvier, Nicolas; Caillard, Sophie; Garrigue, Isabelle; Anglicheau, Dany; Rérolle, Jean-Philippe; Le Meur, Yannick; Durrbach, Antoine; Bachelet, Thomas; Savel, Hélène; Coueron, Roxane; Visentin, Jonathan; Del Bello, Arnaud; Pellegrin, Isabelle; Déchanet-Merville, Julie; Merville, Pierre; Thiébaut, Rodolphe; Couzi, Lionel.
  • Kaminski H; Department of Nephrology, Transplantation, Dialysis and Apheresis, CHU Bordeaux, Bordeaux, France.
  • Kamar N; UMR 5164-ImmunoConcEpT, University of Bordeaux, CNRS, Bordeaux University, Bordeaux, France.
  • Thaunat O; Department of Nephrology and Organ Transplantation, CHU Toulouse, Toulouse, France.
  • Bouvier N; INSERM U1043, IFR-BMT, Toulouse, France.
  • Caillard S; Department of Nephrology, Transplantation and Clinical Immunology of Edouard Herriot Hospital, Hospices Civils de Lyon, Lyon-I University UFR Lyon Est, Lyon, France.
  • Garrigue I; Department of Nephrology, Transplantation, Dialysis, CHU Caen, Caen, France.
  • Anglicheau D; Department of Nephrology and Transplantation, CHU Strasbourg, Strasbourg, France.
  • Rérolle JP; Laboratory of Virology, CHU Bordeaux, Bordeaux, France.
  • Le Meur Y; Department of Nephrology and Kidney Transplantation, Necker Hospital, Assistance Publique-Hôpitaux de Paris, Paris, France.
  • Durrbach A; Department of Nephrology and Transplantation, CHU Limoges, Limoges, France.
  • Bachelet T; Department of Nephrology and Transplantation, Brest University Hospital, Brest, France.
  • Savel H; Department of Nephrology and Kidney Transplantation, INSERM 1186, Henri Mondor Hospital, Assistance Publique-Hôpitaux de Paris, Paris Saclay University, Paris, France.
  • Coueron R; Department of Nephrology, Transplantation, Dialysis and Apheresis, CHU Bordeaux, Bordeaux, France.
  • Visentin J; CHU Bordeaux, Service d'information médicale, Bordeaux, France.
  • Del Bello A; CHU Bordeaux, Service d'information médicale, Bordeaux, France.
  • Pellegrin I; UMR 5164-ImmunoConcEpT, University of Bordeaux, CNRS, Bordeaux University, Bordeaux, France.
  • Déchanet-Merville J; Laboratory of Immunology and Immunogenetics, CHU Bordeaux, Bordeaux, France.
  • Merville P; Department of Nephrology and Organ Transplantation, CHU Toulouse, Toulouse, France.
  • Thiébaut R; INSERM U1043, IFR-BMT, Toulouse, France.
  • Couzi L; UMR 5164-ImmunoConcEpT, University of Bordeaux, CNRS, Bordeaux University, Bordeaux, France.
Am J Transplant ; 22(5): 1430-1441, 2022 05.
Article en En | MEDLINE | ID: mdl-34990047
Asunto(s)
Palabras clave
Texto completo
Imprimir
XML
PubMed Links
Search on Google

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Trasplante de Riñón / Infecciones por Citomegalovirus Tipo de estudio: Clinical_trials / Etiology_studies / Incidence_studies / Prognostic_studies / Risk_factors_studies Límite: Humans Idioma: En Año: 2022 Tipo del documento: Article
Texto completo
Imprimir
XML
PubMed Links
Search on Google

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Trasplante de Riñón / Infecciones por Citomegalovirus Tipo de estudio: Clinical_trials / Etiology_studies / Incidence_studies / Prognostic_studies / Risk_factors_studies Límite: Humans Idioma: En Año: 2022 Tipo del documento: Article